Viking Therapeutics has received a consensus rating of Buy.
Will Qualigen Therapeutics stock go up?
Qualigen Therapeutics Inc (NASDAQ:QLGN) The 1 analysts offering 12-month price forecasts for Qualigen Therapeutics Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +606.44% increase from the last price of 0.92.
What is Viking therapeutics working on?
The Company is focused on the development of novel therapies for metabolic and endocrine disorders. The Company's lead clinical program includes VK2809, which is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta.4 days ago
Is Viking Therapeutics a good stock to buy?
Fair opening price Current price
----------------------------------- -------------------
$3.56 $3.52 (Undervalued)
Will Viking Therapeutics stock go up?
Stock Price Forecast The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +464.97% increase from the last price of 3.54.
Is Viking Therapeutics a buy Zacks?
Zacks' proprietary data indicates that Viking Therapeutics, Inc. is currently rated as a Zacks Rank 3 and we are expecting an inline return from the VKTX shares relative to the market in the next few months. The financial health and growth prospects of VKTX, demonstrate its potential to underperform the market.
Is Applied Therapeutics a buy?
Applied Therapeutics has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.
Will VKTX go up?
The 9 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +464.97% increase from the last price of 3.54.
Is Vikings Therapeutics a buy?
Viking Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
Is Viking a public company?
Type Private
------------ ---------------------------------------------------------------------
Founded 1997
Headquarters Basel, Switzerland
Key people Torstein Hagen, Founder, Chairman Karine Hagen, Senior Vice President